Global Leukemia Therapeutics Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI679487
  • March 18, 2019
  • Global
  • 106 pages
  • QY Market Research

"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Leukemia Therapeutics market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Leukemia Therapeutics market." Leukemia is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. The global Leukemia Therapeutics market is valued at 10100 million US$ in 2018 is expected to reach 13700 million US$ by the end of 2025, growing at a CAGR of 3.8% during 2019-2025. This report focuses on Leukemia Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leukemia Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Roche GlaxoSmithKline Novartis Bristol-Myers Squibb Eisai Biogen Idec ERYtech Pharma Celgene Genmab Cephalon Clavis Pharma Pfizer Segment by Regions North America Europe China Japan Segment by Type Gleevec Sprycel Tasigna Clolar Others Segment by Application Hospital Clinic

Table of Contents

Executive Summary
1 Leukemia Therapeutics Market Overview
    1.1 Product Overview and Scope of Leukemia Therapeutics
    1.2 Leukemia Therapeutics Segment by Type
        1.2.1 Global Leukemia Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Gleevec
        1.2.3 Sprycel
        1.2.4 Tasigna
        1.2.5 Clolar
        1.2.6 Others
    1.3 Leukemia Therapeutics Segment by Application
        1.3.1 Leukemia Therapeutics Consumption Comparison by Application (2014-2025)
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Global Leukemia Therapeutics Market by Region
        1.4.1 Global Leukemia Therapeutics Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Leukemia Therapeutics Market Size
        1.5.1 Global Leukemia Therapeutics Revenue (2014-2025)
        1.5.2 Global Leukemia Therapeutics Production (2014-2025)

2 Global Leukemia Therapeutics Market Competition by Manufacturers
    2.1 Global Leukemia Therapeutics Production Market Share by Manufacturers (2014-2019)
    2.2 Global Leukemia Therapeutics Revenue Share by Manufacturers (2014-2019)
    2.3 Global Leukemia Therapeutics Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Leukemia Therapeutics Production Sites, Area Served, Product Types
    2.5 Leukemia Therapeutics Market Competitive Situation and Trends
        2.5.1 Leukemia Therapeutics Market Concentration Rate
        2.5.2 Leukemia Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Leukemia Therapeutics Production Market Share by Regions
    3.1 Global Leukemia Therapeutics Production Market Share by Regions
    3.2 Global Leukemia Therapeutics Revenue Market Share by Regions (2014-2019)
    3.3 Global Leukemia Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
    3.4 North America Leukemia Therapeutics Production
        3.4.1 North America Leukemia Therapeutics Production Growth Rate (2014-2019)
        3.4.2 North America Leukemia Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
| 

Request a sample

Fill below form to request a sample


Please fill this form to enquire before buying


You can request for discount regarding the report by using below form